This inventor holds 3 USPTO granted patents. Top assignees: Carlo Erba, Farmitalia Carlo Erba. Active years: 1979-1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979-1983
Title: Innovative Mind: The Contributions of Angelo Forgione
Introduction
Angelo Forgione, based in Milan, Italy, is a noteworthy inventor recognized for his contributions to the field of medicinal chemistry. With three patents to his name, he has made significant strides in the development of antibacterial compounds that hold promise for treating various infections.
Latest Patents
Forgione's latest patents focus on the creation of heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acid. These compounds are particularly effective against both Gram-positive and Gram-negative microorganisms. The patents describe the processes for preparing these derivatives and their suitability for treating infections caused by such microorganisms, highlighting their potential in the pharmaceutical industry for developing new antibacterial treatments.
Career Highlights
Throughout his career, Angelo Forgione has worked with esteemed companies such as Carlo Erba S.p.A. and Farmitalia Carlo Erba S.p.A. His time at these organizations enabled him to translate his innovative ideas into practical applications, furthering the advancement of medical treatments.
Collaborations
During his professional journey, Forgione has collaborated with other notable professionals, including Giuliano Nannini and Ettore Perrone. These collaborations have enriched his work and contributed to the successful development of his patented inventions.
Conclusion
Angelo Forgione, with his innovative spirit and dedication to combating infections through advanced medicinal compounds, exemplifies the impact that a single inventor can have in the field of healthcare. His patents not only reflect his personal achievements but also serve as a foundation for future advancements in treating bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile